June 12, 2023 by Jeffrey Woldt
AmerisourceBergen, Chain Drug Review/MMR Video Forum, Claire Biermaas, George Rafferty, Video Forum
Featured Articles, Leading Headlines, Videos

In the second installment of a two-part interview, George Rafferty, who has announced his retirement after heading AmerisourceBergen’s Corporate Partnerships Group for the past five years, and his successor, Claire Biermaas, talk about the leadership transition and the unique culture that enables the drug wholesaler to stay in sync with the evolving needs of its
June 5, 2023 by Jeffrey Woldt
AmerisourceBergen, Claire Biermaas, Corporate Partnerships Group, George Rafferty
Featured Articles, Leading Headlines, Videos

This week’s Video Forum offers a look at the leadership transition now under way at AmerisourceBergen’s Corporate Partnerships Group. In the first of two installments, George Rafferty, who has headed the program since its inception five years ago, and Claire Biermaas, who is succeeding him as president of corporate partnerships, share their perspectives on the
July 18, 2022 by Jeffrey Woldt
AmerisourceBergen, DEI, diversity, equity, inclusion, Lamont Robinson, minority owned, Veteran Owned, women-owned
Featured Articles, Leading Headlines, Videos

In this week’s Video Forum, Lamont Robinson, director of supply diversity at AmerisourceBergen, discusses the origins of diversity, equity and inclusion programs and the company’s commitment to leadership in the field. He also addresses the benefits that veteran-owned, women-owned, minority-owned and other diverse businesses derive from AmerisourceBergen’s DEI efforts and his passion for his work.
May 12, 2022 by MMR
AmerisourceBergen, Ornella Barra, Rosalind Brewer, Walgreens Boots Alliance
Leading Headlines, Money, Retail News

DEERFIELD, Ill.– Walgreens Boots Alliance, Inc. (WBA) has sold 6.0 million shares of AmerisourceBergen Corp. common stock pursuant to Rule 144 at a price of $150 per share. After the sale, Walgreens Boots Alliance’s ownership of AmerisourceBergen’s common stock decreased from approximately 28.1% to approximately 25.2%. The sale has no impact on the long-term partnership
April 4, 2022 by Jeffrey Woldt
AmerisourceBergen, Chain Drug Review/MMR Video Forum, Claire Biermaas, George Rafferty, Video Forum
Featured Articles, Leading Headlines, Videos

This week’s Video Forum features the second installment of a two-part interview with George Rafferty and Claire Biermaas, president and vice president of corporate partnerships, respectively, at AmerisourceBergen. Among the subjects they discuss are the importance of communication and diversity of thought in finding the best solutions for customers, the enhancement of the technology systems
March 28, 2022 by Jeffrey Woldt
AmerisourceBergen, Claire Biermass, George Rafferty
Featured Articles, Leading Headlines, Videos

George Rafferty and Claire Biermaas, president and vice president of corporate partnerships, respectively, at AmerisourceBergen, tell Video Forum about the “radical curiosity” that the pharmaceutical wholesaler brings to the task of supporting its largest accounts. In the first part of a two-part interview, Rafferty and Biermaas address the genesis of the corporate partnerships program, their
February 25, 2022 by MMR
AmerisourceBergen, Cardinal Health and McKesson, opioid lawsuits
Leading Headlines

NEW YORK — AmerisourceBergen, Cardinal Health and McKesson announced Friday that each company has independently determined that there is sufficient participation by states and litigating political subdivisions to proceed with a comprehensive agreement to settle the vast majority of the opioid lawsuits filed by state and local governmental entities. The companies have previously disclosed that
October 25, 2021 by Jeffrey Woldt
AmerisourceBergen, Brian Nightengale, Chain Drug Review/MMR Video Forum
Featured Articles, Leading Headlines, Videos

In the second installment of a two-part interview, Brian Nightengale, president of community and specialty pharmacy and long-term care at AmerisourceBergen, discusses where specialty medications fit in the retail landscape and the shifting dynamics in long-term care. In addition, he talks about the reasons he remains optimistic about the future of the pharmacy profession.
October 18, 2021 by Jeffrey Woldt
AmerisourceBergen, Brian Nightengale, Good Neighbor Pharmacy, pharmacy reimbursement
Featured Articles, Leading Headlines, Videos

In the first installment of a two-part interview, Brian Nightengale, newly appointed president of community and specialty pharmacy and long-term care at AmerisourceBergen, talks about the company’s Good Neighbor Pharmacy network, the expanded scope of his responsibilities, and Jennifer Zilka, his successor as president of Good Neighbor. In addition, Nightengale offers insights about the slowly
June 2, 2021 by MMR
Alliance Healthcare, AmerisourceBergen, Walgreens Boots Alliance
Leading Headlines, Money, Retail News

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) has finalized the sale of its Alliance Healthcare businesses to AmerisourceBergen. The $6.5 billion deal included $6.275 billion in cash (subject to a customary net cash and working capital adjustment) and 2 million shares of AmerisourceBergen common stock. WBA said it will use the cash proceeds to reduce
February 22, 2021 by Jeffrey Woldt
AmerisourceBergen, Claire Biermaas, Mike Amante
Featured Articles, Leading Headlines, Videos

In this week’s Video Forum, AmerisourceBergen group vice president of corporate partnerships Claire Biermaas and vice president of strategic solutions Mike Amante discuss the health services company’s efforts to cement its position as an essential partner for its top customers. The executives outline how AmerisourceBergen’s design thinking process results in a shared strategic vision.
January 25, 2021 by Jeffrey Woldt
AmerisourceBergen, Chain Drug Review/MMR Video Forum, George Rafferty
Featured Articles, Leading Headlines, Videos

In this week’s Video Forum, George Rafferty, president of corporate partnerships at AmerisourceBergen, discusses the drug wholesaler’s innovative go-to-market strategy. The new model aims to provide customers with top-notch day-to-day support, while at the same time fostering more strategic, long-term relationships.